Skip to main content
Clinical Trials/NCT05273645
NCT05273645
Unknown
Not Applicable

World-wide Survey on the Incidence, Diagnosis and Prognosis of Atrio-oesophageal Fistula Following Percutaneous Catheter Ablation

University of Luebeck1 site in 1 country50 target enrollmentMarch 31, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
University of Luebeck
Enrollment
50
Locations
1
Primary Endpoint
Incidence of AOF following percutaneous catheter ablation
Last Updated
4 years ago

Overview

Brief Summary

Pulmonary vein isolation emerged as an effective and safe strategy to treat atrial fibrillation patients. Atrio-oesophageal fistula (AOF) represents a rare but devastating complication of AF ablation procedure. This complication (0.016-0.07%) requires an international effort to allow for better understanding of the factors contributing to its occurrence and the best management strategies. A worldwide, retrospective, multicenter registry focusing on the incidence, diagnosis and management of this complication.

Detailed Description

Data about the incidence, optimal management and outcome of AOF is sparse. The largest national and international surveys report on less than 50 AOF. The latest worldwide survey was conducted in 2015 and managed to include 31 patients who developed AOF after atrial fibrillation ablation procedure. In the meanwhile, the total number of AF ablation procedures increased significantly. Additionally, AF ablation technology changes significantly with e.g. increasing numbers of cryoballoon ablation and contact force guided radiofrequency ablation. The study is designed as a worldwide, multi-centre, anonymised registry study to evaluate the incidence, optimal management and outcome of this AOF. More than 50 patients with AOF following percutaneous catheter ablation will be included in the register.

Registry
clinicaltrials.gov
Start Date
March 31, 2022
End Date
February 28, 2024
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Luebeck
Responsible Party
Principal Investigator
Principal Investigator

Prof. Roland Richard Tilz

Prof. Dr. med. Roland Richard Tilz

University of Luebeck

Eligibility Criteria

Inclusion Criteria

  • Atrio-oesophageal fistula after Ablation
  • Indication for AF ablation as per current guidelines
  • Performing the ablation at an ablation centre

Exclusion Criteria

  • No Atrio-oesophageal fistula after Ablation

Outcomes

Primary Outcomes

Incidence of AOF following percutaneous catheter ablation

Time Frame: 5 year

1. Evaluating the Incidence of atrio-oesophageal fistula after percutaneous catheter ablation in patients with atrial fibrillation, as well as the more detailed analysis of the incidence of AOF after PVI with Cryo Balloon or RF Contact Force

Secondary Outcomes

  • Diagnosis and management of AOF(5 year)
  • Mortality rate(5 year)

Study Sites (1)

Loading locations...

Similar Trials